Form 8-K - Current report:
SEC Accession No. 0001437749-23-035326
Filing Date
2023-12-26
Accepted
2023-12-26 17:27:27
Documents
13
Period of Report
2023-12-26
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K amti20231222c_8k.htm   iXBRL 8-K 32288
  Complete submission text file 0001437749-23-035326.txt   164492

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA amti-20231226.xsd EX-101.SCH 3411
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amti-20231226_def.xml EX-101.DEF 11426
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE amti-20231226_lab.xml EX-101.LAB 15312
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amti-20231226_pre.xml EX-101.PRE 11586
7 EXTRACTED XBRL INSTANCE DOCUMENT amti20231222c_8k_htm.xml XML 2560
Mailing Address C/O THE CORPORATION TRUST COMPANY CORPORATION TRUST CENTER, 1209 ORANGE ST WILMINGTON DE 19801
Business Address C/O THE CORPORATION TRUST COMPANY CORPORATION TRUST CENTER, 1209 ORANGE ST WILMINGTON DE 19801 650-392-0420
Applied Molecular Transport Inc. (Filer) CIK: 0001801777 (see all company filings)

EIN.: 814481426 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39306 | Film No.: 231514193
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)